With a situation as complex as RXPC's is, there are multiple components that make up each of the major developments currently taking place.
Nice to see that Provista is able to raise money to expand their development of dtectDx-Breast. Naturally I am more curious about the "pursuing additional clinical trials" portion of their statement. Of the $19.5 million raised, I wonder how much is still on hand.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.